Background. Individuals with major depressive disorder (MDD) are characterized by maladaptive responses to both positive and negative outcomes, which have been linked to localized abnormal activations in cortical and striatal brain regions. However, the exact neural circuitry implicated in such abnormalities remains largely unexplored.
Introduction
Major depressive disorder (MDD) is a highly prevalent psychiatric condition characterized by a range of abnormal behaviors, including dysregulated responses to both positive and negative outcomes. Functional magnetic resonance imaging (fMRI) studies have described reduced responsivity in localized brain regions including the ventral [nucleus accumbens (Nacc)] and dorsal (caudate) striatum in response to a variety of positive stimuli in individuals with MDD (Lawrence et al. 2004; Forbes et al. 2006 Forbes et al. , 2009 Schaefer et al. 2006; Kumar et al. 2008; Smoski et al. 2009 ). Blunted reward-related striatal responsiveness in MDD has been associated with decreased positive affect (Forbes et al. 2009 ), in line with the well-established role of the striatum in reward processing (Haber & Knutson, 2010) . Depression, however, is a highly complex construct and thus is likely to involve circuit-level alterations rather than isolated dysfunction in discrete brain regions (Mayberg, 1997) . Indeed, using functional connectivity analyses, Heller et al. (2009) found that the inability to sustain positive affect in MDD was associated with reduced frontostriatal connectivity in addition to blunted striatal activation. Despite these promising results, the neural circuitry underlying abnormal responses to positive outcomes in MDD remains largely unexplored. The first aim of the current study was to fill this gap by investigating whether MDD is characterized by abnormal striatal connectivity in response to monetary gains.
Of note, neuroimaging studies in healthy populations have also demonstrated striatal involvement in response to aversive stimuli. For example, the ventral striatum (i.e. the Nacc) was shown to respond to thermal pain (Becerra et al. 2001; Baliki et al. 2013 ) whereas the dorsal striatum (i.e. the caudate) responded to electric shock and monetary losses (Tricomi et al. 2004; Seymour et al. 2007; Delgado et al. 2008; Mattfeld et al. 2011; Niznikiewicz & Delgado, 2011) . Indeed, among healthy controls (HCs), both monetary gains and penalties were found to elicit increased bilateral caudate activations (Pizzagalli et al. 2009 ). Moreover, relative to HCs, MDD patients showed significantly lower caudate activation to both gains and penalties (Pizzagalli et al. 2009 ), suggesting that blunted caudate responsivity in MDD might extend to a broad range of affective stimuli. Thus, our second aim was to test whether putative striatal connectivity disruptions in MDD are valence dependent. This was achieved by implementing psychophysiological interaction (PPI) analysis, enabling the identification of brain regions whose direct connectivity changes in a given psychological context (Friston et al. 1997; O'Reilly et al. 2012) . To this end, whole-brain PPI analyses were conducted separately for gain and penalty outcomes using the caudate as a seed. Following the fMRI scan, depressed individuals were enrolled in a 12-week, randomized, double-blind, placebo-controlled clinical trial comparing escitalopram and S-adenosyl-L-methionine (SAMe), a dietary supplement with antidepressant properties (Papakostas et al. 2010; Mischoulon et al. 2013) . As an exploratory third aim we investigated whether pre-treatment PPI connectivity values predicted symptom change 12 weeks later.
Method

Participants
Recruitment procedures and sample characteristics have been described previously in detail (Pizzagalli et al. 2009 ). In brief, depressed participants (n = 30; 15 males) had a diagnosis of MDD according to the SCID (First et al. 2002) , and a score 516 on the 21-item Hamilton Depression Rating Scale (HAMD-21; Hamilton, 1967) . Exclusion criteria included: any psychotropic medication in the past 2 weeks (6 weeks for fluoxetine; 6 months for dopaminergic drugs or neuroleptics); a current or past history of MDD with psychotic features; and presence of other Axis I diagnoses (including lifetime substance dependence and any substance use disorder in the past year), with the exception of anxiety disorders. Specifically, 11 depressed participants had a current anxiety disorder (37% of the sample) and three had subthreshold anxiety symptoms (10% of the sample).
Comparison subjects (n = 31; 18 males) were recruited from the community. They reported no medical or neurological illness, no current or past psychopathology (according to the SCID), and no use of psychotropic medications. As summarized in the online Supplementary Table S1, MDD and comparison groups were demographically matched in age, years of education, gender and ethnicity. All participants were right-handed and provided written informed consent to a protocol approved by the Committee on the Use of Human Subjects in Research at Harvard University and the Partners Human Research Committee.
Monetary incentive delay task
A graphical description of the task is presented in Supplementary Fig. S1 . In brief, trials began with a visual cue (1.5 s) indicating the potential outcome (reward: +$; loss: −$; no incentive: 0$). After a variable interstimulus interval (3-7.5 s), a red target square was presented briefly, to which subjects responded by pressing a button. After a second variable delay (4.4-8.9 s), visual feedback (1.5 s) indicated the trial outcome (gain, penalty, no change). A variable interval (3-12 s) separated the trials. The task involved five blocks of 24 trials each. Gains and penalties were delivered in a predetermined pattern to allow a balanced design. For each block, half of the reward trials yielded a monetary gain (range = US$1.96-US$2.34, mean = US$2.15) and half ended with no-change feedback. Similarly, half of the loss trials yielded a monetary penalty (range = US $1.81-US$2.19, mean = US$2.00), and half resulted in no change. No-incentive trials always ended with no-change feedback. Despite these predetermined outcomes, participants were told that responding rapidly would maximize their chances of obtaining gains and avoiding penalties. To maximize the perception of contingency between outcomes and participants' responses, target presentation duration was individually titrated to be longer for trials scheduled to be successful than for those scheduled to be unsuccessful.
Data acquisition
Data were collected on a 1.5-T Symphony/Sonata scanner (Siemens Medical Systems, USA) and consisted of a T1-weighted magnetization prepared rapid gradient echo (MPRAGE) fMRI data analysis fMRI data were analyzed using the Oxford Centre for Functional MRI of the Brain (FMRIB) Software Library (FSL) version 4.1.5 (Smith et al. 2004 ; http://fsl.fmrib.ox. ac.uk/fsl/fslwiki/). Data preprocessing included: motion correction using MCFLIRT (Jenkinson et al. 2002) , slice timing correction, removal of non-brain structures using BET (Smith, 2002) , spatial smoothing (6 mm), grand mean intensity normalization, and highpass temporal filtering (σ = 60 s). Registration of functional data to the high-resolution structural images was achieved using the linear registration tool in FSL, FLIRT (Jenkinson et al. 2002) , and registration of structural images to the 2-mm Montreal Neurological Institute (MNI) standard space template was performed using the non-linear registration tool FNIRT (Smith et al. 2004) . Data for four MDD and two control subjects were lost because of excessive motion (>2 mm), leaving 26 individuals in the MDD group and 29 in the controls. Notably, the present study included two fewer participants than our previous report (Pizzagalli et al. 2009 ) because of a stricter motion correction exclusion criterion, as motion can have a particularly strong impact on connectivity analyses (Power et al. 2012) . Hemodynamic responses were modeled using a gamma function and convolved with onset times of cues and outcomes to form the general linear model (GLM) at the single subject level. The six rigid-body movement parameters, target and error trials were included in the GLM as covariates of no interest. Our previous analysis of this sample revealed that the differences in brain function between HCs and MDD subjects were much more robust in response to outcomes than cues (Pizzagalli et al. 2009 ). Thus, current analyses focused on connectivity abnormalities in response to outcome stimuli only. To probe caudate responsivity and connectivity to both monetary outcomes in a balanced way, contrast maps were created by comparing responses to gains and penalties outcomes versus responses to neutral outcome (gain = +1, penalty = +1, no-change = −2). These subject-level contrast maps were transformed to MNI standard space (2 mm) using the transformation matrices from the registration step during pre-processing. Group differences were evaluated using a random effects higherlevel GLM (two-group unpaired t test). Left and right caudate regions of interest (ROIs) were defined by conducting a conjunction between functional and anatomical masks of the caudate. The functional caudate cluster was derived from the map of significant group differences (controls > MDD) in responses to gains and penalties outcomes versus responses to neutral outcome (p < 0.005 or Z > 2.58, uncorrected for multiple comparisons across voxels), whereas the anatomical caudate template was taken from the Harvard-Oxford subcortical structural atlas (likelihood > 20%) (Desikan et al. 2006) . These group-level ROIs were then warped into each individual's native space to identify subject-specific caudate ROIs from which average blood oxygen level-dependent (BOLD) signal parameter estimates were extracted separately for gain, penalty and no-change outcomes. Next, left and right caudate ROIs were merged to create a single ROI mask of the bilateral caudate from which timecourses were extracted for PPI analyses. For each subject, subject-level GLMs were constructed as described above, with the addition of the bilateral caudate seed time-course as a regressor and three additional PPI regressors, that is the product of the seed time-course and the regressors for gain, penalty and no-change outcomes. These regressors are orthogonal to the task and seed regressors, and thus describe the contribution of the interaction above and beyond the main effects of the task and seed time-course. In addition, the orthogonality of the task and PPI regressors ensures that the approach used to identify the caudate seed ROI for the PPI is not circular (McLaren et al. 2012) . Contrasts for each PPI were assessed for group differences using a higher-level GLM (two-group unpaired t test). Inference at the whole-brain level was made using clusters determined by Z > 2.3 and a corrected cluster significance threshold of p = 0.05 (using Gaussian random field theory; Worsley, 2001 ).
Treatment and symptom evaluation
Patients in the current study were chosen randomly to undergo an fMRI scan from a larger pool of depressed individuals (n = 189) enrolled in a multi-site randomized, double-bind, placebo-controlled clinical trial comparing the dietary supplement SAMe (1600-3200 mg/day) and escitalopram (10-20 mg/day) over a 12-week treatment period (Mischoulon et al. 2013) . SAMe treatment was investigated because of previous reports supporting its antidepressant efficacy as monotherapy against placebo and tricyclic antidepressants (Papakostas et al. 2003; Papakostas, 2009) . Notably, the larger clinical trial revealed that depressive symptoms significantly improved over the 12 treatment weeks; however, both the primary outcome measure [percentage symptom change from pre-to post-treatment, defined as (HAMD-17 pre -HAMD-17 post )/(HAMD-17 pre ) × 100] and secondary outcome measures (treatment response and remission rate, defined as 550% pre-to post-treatment reduction in HAMD-17 scores and a post-treatment HAMD-17 score 47, respectively) revealed no significant difference among the three treatment arms: escitalopram, SAMe and placebo (Mischoulon et al. 2013) . As depicted in Table 1 , the sample that underwent fMRI prior to their enrollment in the clinical trial was equally randomized to the three treatment arms, displayed no differences in treatment completion rate, and showed comparable efficacy among treatment arms. Thus, the fMRI sample is representative of the larger clinical trial sample. In light of these outcome data, the pretreatment PPI connectivity values for the 14 MDD patients who completed the 12-week treatment were aggregated across treatments and tested as predictors of clinical outcome using regression analyses.
Results
Caudate activation in response to gains and penalties
Whole-brain analysis revealed weaker bilateral caudate activation to incentives in MDD compared to controls (Fig. 1a) . As depicted in Table 2 , the location of those clusters matches those described in our prior analyses (Pizzagalli et al. 2009 
Caudate connectivity in response to gains and penalties
Whole-brain PPI analyses revealed a single cluster, located in the dorsal section of anterior cingulate cortex (dACC), that was more functionally connected to the caudate in controls compared to depressed participants during gain outcomes. By contrast, a different dACC cluster was found to be more functionally connected to the caudate in MDD compared to controls during penalties (Fig. 2a , blue and red respectively, and Table 3 ). No clusters showed stronger connection with the caudate in controls compared to MDD during penalty outcomes or in MDD compared to controls during gain outcomes. Furthermore, no group PPI differences emerged during neutral outcomes. Figure 2b depict the mean connectivity values as extracted from each dACC ROI for each condition. Importantly, the opposite pattern of abnormal connectivity in MDD suggests that their diminished caudate activation did not bias the PPI analyses. Indeed, regression analyses of the extracted connectivity values revealed that group differences in connectivity remained significant even after accounting for caudate activation as a covariate (p = 0.018 and p = 0.005 for gain and penalty respectively). Notably, although both dACC clusters were within Brodmann area (BA) 24, they were distinct and spatially segregated. For the sake of simplicity, the dACC cluster that was more connected to the caudate in controls during positive outcomes (monetary gains) is referred to hereafter as dACC 1 , and the one that was more connected to the caudate in MDD during SAMe, S-adenosyl-L-methionine. a Because of the limited sample size, the three treatment arms were compared using a Kruskal-Wallis non-parametric ANOVA.
The three treatment arms were comparable across all measures, mirroring patterns observed in the larger clinical trial (Mischoulon et al. 2013). negative outcomes (monetary penalties) is referred to as dACC 2 (Fig. 2a, blue and red respectively) .
Prediction of symptom change
Regression analyses revealed that neither pre-treatment dACC 1 -caudate connectivity during gains nor pretreatment dACC 2 -caudate connectivity during penalties was associated with the percentage symptom change 12 weeks later (r = 0.23, p = 0.42 and r = 0.08, p = 0.79 respectively). Notably, both connectivity measures were also not associated with baseline depressive severity (pre-treatment HAMD-17 score) (r =0.2, p = 0.33 and r = 0.03, p = 0.9 for dACC 1 -caudate and dACC 2 -caudate connectivity, respectively).
Next, we evaluated whether simultaneously accounting for connectivity abnormalities to both outcomes would increase prediction accuracy. This was done because of the demonstrated abnormalities in response to both positive and negative outcomes in our MDD sample, in addition to previous findings indicating that responses to positive and negative contexts contribute mutually to depression course (Rottenberg et al. 2002) . Furthermore, various event-related potential (ERP) studies have shown that a difference (composite) score in the feedback-related negativity (FRN) in response to monetary reward and loss correlated with depression severity (Foti & Hajcak, 2009) , and predicted future first onset of MDD (Bress et al. 2013) . Directly relevant to the current study, the FRN is thought to originate from the ACC (Gehring & Willoughby, 2002) , further corroborating our approach. Thus, the individuals' dACC 2 -caudate connectivity during penalty was subtracted from dACC 1 -caudate connectivity during gain, yielding a composite measure for which decreasing scores highlight greater deviation from the HCs' pattern. Regression analyses revealed that the composite connectivity score was not associated with baseline depression severity (r = 0.35, p = 0.09), but was significantly positively correlated with the percentage symptom change (F 12 = 6.92, r = 0.61, p = 0.022). Accordingly, the higher the score (i.e. the more normative the pre-treatment pattern of cortico-striatal connectivity), the more the symptoms improved 12 weeks later (Fig. 3) . To test the specificity and robustness of these findings, we conducted a hierarchical regression analysis in which treatment arm (dummy coded), gender, baseline depressive severity and caudate (seed) activation to gain and penalty outcomes were entered in the first step, followed by the composite connectivity score in the second step; the percentage symptom change was the dependent variable. The model in the first step was not significant (F = 1.14, p = 0.4, r = 0.4). When entering the composite score in the second step, the model became significant (F change = 6.61, p change = 0.033, r change = 0.56, R 2 change = 0.36), indicating that the association between percentage symptom change and pre-treatment cortico-striatal connectivity remained significant even when accounting for baseline depression severity, gender and treatment arm.
Discussion
Following the demonstration of blunted caudate responsiveness to positive and negative outcomes in MDD (Pizzagalli et al. 2009 ), the overarching aim of the present study was to evaluate whether unmedicated MDD individuals are also characterized by disrupted, valence-dependent, caudate connectivity. Using PPI whole-brain analyses in a relatively large sample involving 26 unmedicated individuals with MDD and 29 HCs, we identified spatially distinct dACC regions characterized by opposite patterns of abnormal caudate connectivity in MDD in response to positive and negative outcomes. Specifically, one dACC subregion showed decreased connectivity with the caudate during gain outcomes, whereas a distinct dACC subregion showed increased connectivity with the caudate during penalty outcomes relative to HCs. In addition, an exploratory analysis revealed The results emerged from a whole-brain family-wise error (FWE)-corrected (p < 0.05) psychophysiological interaction (PPI) analyses using the bilateral caudate as a seed.
(a) ( b) Fig. 2 . (a) Two distinct dorsal anterior cingulate cortex (dACC) clusters with opposite caudate connectivity abnormalities in major depressive disorder (MDD). dACC 1 (blue) was more functionally connected to the caudate in healthy controls (HCs) compared to MDD subjects during gains, whereas dACC 2 (red) was more functionally connected to the caudate in MDD compared to HCs during penalties. (b) Mean parameter estimates (connectivity values) from each dACC section for each condition. Bars ±1 s.E.M. * p < 0.05, ** p < 0.005.
that a more normative pattern of pre-treatment cortico-striatal connectivity predicted greater improvement in symptoms following a 12-week treatment period. Previous findings in healthy subjects have implicated the caudate-dACC circuitry in the establishment of contingency between a given action and its outcome, regardless of its valence (Tricomi et al. 2004; Niznikiewicz & Delgado, 2011) . Specifically, in prior studies, striatal function was interpreted as indicating a mismatch between expected and experienced outcomes (prediction error) (Delgado, 2007; Rangel et al. 2008) , whereas dACC function was associated with individuals' evaluation of their control over a given process (Shenhav et al. 2013) . In light of these findings, altered cortico-striatal connectivity in MDD may hamper learning action-outcome contingencies, which in turn might disrupt goal-directed behavior. In particular, reduced synchronization between the caudate and dACC 1 in response to monetary gains in MDD may reflect impaired functional integration in this circuitry during positive feedback, which might reduce the saliency of such feedback in reinforcing a repetition of this (successful) action. In support of this interpretation, compared to HCs, individuals with MDD show a lower probability of repeating an action that leads to a positive feedback or reward Liu et al. 2011; Vrieze et al. 2013) , and weaker behavioral modulation of incentives (Pizzagalli et al. 2009 ). In addition, a blunted caudate responsiveness in MDD emerged while patients learned to associate their actions with the receipt of unpredictable reward (Kumar et al. 2008; Pizzagalli et al. 2009; Smoski et al. 2009 ), yet no caudate abnormalities in MDD emerged when rewards were more predictable (Knutson et al. 2008) . By contrast, increased caudate-dACC 2 connectivity during penalties may represent a neural mechanism for the abnormally increased representation of negative feedback upon the completion of an (unsuccessful) action in MDD. Indeed, depressed individuals amplify the significance of failures relative to controls (Wenzlaff & Grozier, 1988) , potentially leading to the commitment of more errors after an initial mistake (Beats et al. 1996; Elliott et al. 1996; Steffens et al. 2001; Pizzagalli et al. 2006; Holmes & Pizzagalli, 2008) . Intriguingly, inaccurate estimation of contingencies between behaviors and emotional outcomes has long been considered a characterizing feature of MDD (Alloy & Abramson, 1979) . Furthermore, contingency deficiencies in response to affective outcomes fit with two classical models of MDD: Seligman's learned helplessness model (Seligman, 1972 ) and Beck's cognitive theory (Beck, 2005) . The first posits that MDD patients grow to accept that negative circumstances cannot be altered through their own actions (Seligman, 1972) , whereas the second proposes that depression is associated with biased processing of feedback information in such a way that depressed individuals fail to interpret positive events as resulting from their owns' actions yet overattribute negative events to their actions (Beck, 2005) . Whether disrupted cortico-striatal connectivity is indeed linked to these cognitive diatheses is currently unknown and warrants further inquiry.
Of note, caudate-dACC connectivity before treatment was associated with symptom changes 12 weeks later, even when accounting for pre-treatment depression severity. This novel finding should be regarded as preliminary given that the current sample size prevented us from comparing individuals who reached remission versus those who did not, and also from differentiating between treatment arms. Indeed, symptom change was predicted regardless of whether it was achieved through pharmacology, a dietary supplement with antidepressant properties, or placebo. Therefore, we can only speculate that a more normative pattern of pre-treatment caudate-dACC connectivity may be associated with larger and global clinical improvement. Further highlighting the role of these neural pathways in clinical course, treatmentinduced normalization of frontostriatal functional connectivity was found to correlate positively with increases in positive affect (Heller et al. 2013) . Importantly, clinical improvement was achieved through either venlafaxine or fluoxetine, suggesting that the mechanism of action fostering improvements in positive affect and frontostriatal connectivity did not differ between the two antidepressants (Heller et al. 2013) . Similarly, a recent meta-analysis indicated that increased pre-treatment ACC and striatum activation is a robust predictor of positive response to both pharmacological and behavioral treatment in MDD (Fu et al. 2013) . Moreover, the ACC cluster identified by Fu et al. (2013) overlaps with the dACC cluster emerging from the current connectivity analyses and predicting symptom improvement following treatment. Lastly, it should be noted that MDD subjects were also shown to exhibit abnormalities in the integrity of the internal capsule fibers, which connect striatal and cingulate regions (Zou et al. 2008; Zhu et al. 2011; Zhang et al. 2013) , and that decreased whitematter volume in the internal capsule predicted treatment non-response to pharmacology (Phillips et al. 2012) . Conversely, deep brain stimulation (DBS) to the internal capsule has been found to reduce depressive symptoms in severely depressed, treatment-resistant MDD patients (Blomstedt et al. 2011) , and stimulate cingulate regions in non-human primates (Knight et al. 2013) . Accordingly, the current cortico-striatal connectivity findings and prior findings highlight a key role of this circuitry in the pathophysiology of MDD and mechanisms of treatment response.
In summary, we have demonstrated that, compared to HCs, depressed individuals exhibit abnormal caudate connectivity with the dACC and, furthermore, that such dysregulated cortico-striatal connectivity is both incentive dependent and predictive of treatment response. These findings may account for the commonly observed reduced action-outcome contingency learning in MDD, which may disrupt goal-directed behavior and represent a central feature of anhedonic behavior in MDD. 
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